Resistin concentration and gestational diabetes: A systematic review of the literature

Journal of Reproductive Immunology

Volumn 97, Issue 1, 2013, Pages 120-127

  Lobo, Thalita Frutuoso ^a   Torloni, Maria Regina ^a   Gueuvoghlanian Silva, Barbara Yasmin ^a   Mattar, Rosiane ^a   Daher, Silvia ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adipokines; Gestational diabetes; Insulin resistance; Resistin

Indexed keywords

RESISTIN;

ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GESTATIONAL AGE; HUMAN; META ANALYSIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADIPOKINES; ANIMALS; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; HUMANS; INSULIN RESISTANCE; PREGNANCY; RESISTIN;

EID: 84874530908     PISSN: 01650378     EISSN: 18727603     Source Type: Journal    
DOI: 10.1016/j.jri.2012.10.004     Document Type: Article

References (40)

1. Akdeniz N., Kuyumcuoglu U., Kale A., Arikan S., Kale E., Erdemoglu M. Resistin may not associate with gestational diabetes mellitus although insulin resistance. Clin. Exp. Obstet. Gynecol. 2011, 38:236-238.
2. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl. 1):S64-S71.
3. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773-1779.
4. Catalano P.M., Kirwan J.P., Haugel-de Mouzon S., King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J. Nutr. 2003, 133:1674S-1683S.
5. Chen D., Fang Q., Chai Y., Wang H., Huang H., Dong M. Serum resistin in gestational diabetes mellitus and early postpartum. Clin. Endocrinol. (Oxf.) 2007, 67:208-211.
6. Cortelazzi D., Corbetta S., Ronzoni S., Pelle F., Marconi A., Cozzi V., et al. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies. Clin. Endocrinol. (Oxf.) 2007, 66:447-453.
7. D'Ippolito S., Tersigni C., Scambia G., Di Simone N. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 2012, 38:14-23.
8. Degawa-Yamauchi M., Bovenkerk J.E., Juliar B.E., Watson W., Kerr K., Jones R., et al. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 2003, 88:5452-5455.
9. Fujinami A., Obayashi H., Ohta K., Ichimura T., Nishimura M., Matsui H., et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta 2004, 339:57-63.
10. Gül G., Onur E., Nazli G.K., Hacer ç., Yasar A., Berrin D., et al. The relation of obesity with serum resistin levels in smoker and nonsmokers. J. Res. Med. Sci. 2012, 17:119-122.
11. Hasselblad V., McCrory D.C. Meta-analytic tools for medical decision making: a practical guide. Med. Decis. Making 1995, 15:81-96.
12. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557-560.
13. Hivert M.F., Manning A.K., McAteer J.B., Dupuis J., Fox C.S., Cupples L.A., et al. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes 2009, 58:750-756.
14. Jenum A.K., Morkrid K., Sletner L., Vangen S., Torper J.L., Nakstad B., et al. Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur. J. Endocrinol. 2012, 166:317-324.
15. Kralisch S., Stepan H., Kratzsch J., Verlohren M., Verlohren H.J., Drynda K., et al. Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur. J. Endocrinol. 2009, 160:33-38.
16. Kulik-Rechberger B., Mora-Janiszewska O. Serum resistin concentrations in cases of gestational diabetes mellitus with good glycemic control and in cord blood. Ginekol. Pol. 2009, 80:432-436.
17. Kusminski C.M., McTernan P.G., Kumar S. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin. Sci. (Lond.) 2005, 109:243-256.
18. Kuzmicki M., Telejko B., Szamatowicz J., Zonenberg A., Nikolajuk A., Kretowski A., et al. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol. Endocrinol. 2009, 25:258-263.
19. Lain K.Y., Daftary A.R., Ness R.B., Roberts J.M. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin. Endocrinol. (Oxf.) 2008, 69:407-411.
20. Lappas M., Yee K., Permezel M., Rice G.E. Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies. J. Endocrinol. 2005, 186:457-465.
21. Lau C.H., Muniandy S. Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann. Hum. Genet. 2011, 75:370-382.
22. Lee J.H., Chan J.L., Yiannakouris N., Kontogianni M., Estrada E., Seip R., et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 2003, 88:4848-4856.
23. Lowe L.P., Metzger B.E., Lowe W.L., Dyer A.R., McDade T.W., McIntyre H.D. Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. J. Clin. Endocrinol. Metab. 2010, 95:5427-5434.
24. McTernan P.G., Fisher F.M., Valsamakis G., Chetty R., Harte A., McTernan C.L., et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 2003, 88:6098-6106.
25. Megia A., Vendrell J., Gutierrez C., Sabate M., Broch M., Fernandez-Real J.M., et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur. J. Endocrinol. 2008, 158:173-178.
26. Nanda S., Poon L.C., Muhaisen M., Acosta I.C., Nicolaides K.H. Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies. Metabolism. 2012, 61:699-705.
27. Nien J.K., Mazaki-Tovi S., Romero R., Kusanovic J.P., Erez O., Gotsch F., et al. Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. J. Perinat. Med. 2007, 35:513-521.
28. Norata G.D., Ongari M., Garlaschelli K., Tibolla G., Grigore L., Raselli S., et al. Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J. Intern. Med. 2007, 262:104-112.
29. Normand S.L. Meta-analysis: formulating, evaluating, combining, and reporting. Stat. Med. 1999, 18:321-359.
30. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72:219-246.
31. Palik E., Baranyi E., Melczer Z., Audikovszky M., Szocs A., Winkler G., et al. Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res. Clin. Pract. 2007, 76:351-357.
32. Pfutzner A., Langenfeld M., Kunt T., Lobig M., Forst T. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin. Lab. 2003, 49:571-576.
33. Rea R., Donnelly R. Resistin: an adipocyte-derived hormone. Has it a role in diabetes and obesity?. Diabetes Obes. Metab. 2004, 6:163-170.
34. Shea B.J., Grimshaw J.M., Wells G.A., Boers M., Andersson N., Hamel C., et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med. Res. Methodol. 2007, 7:10.
35. Shetty G.K., Economides P.A., Horton E.S., Mantzoros C.S., Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004, 27:2450-2457.
36. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., et al. The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
37. Vitoratos N., Dimitrakaki A., Vlahos N.F., Gregoriou O., Panoulis K., Christopoulos P., et al. Maternal and umbilical resistin levels do not correlate with infant birth weight either in normal pregnancies and or in pregnancies complicated with gestational diabetes. J. Matern. Fetal Neonatal Med. 2010, 23:1019-1023.
38. Vitoratos N., Deliveliotou A., Dimitrakaki A., Hassiakos D., Panoulis C., Deligeoroglou E., et al. Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies. J. Obstet. Gynaecol. Res. 2011, 37:112-118.
39. Whiting P., Rutjes A.W., Reitsma J.B., Bossuyt P.M., Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med. Res. Methodol. 2003, 3:25.
40. Zavalza-Gomez A.B., Anaya-Prado R., Rincon-Sanchez A.R., Mora-Martinez J.M. Adipokines and insulin resistance during pregnancy. Diabetes Res. Clin. 2008, 80:8-15.